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Abstract
Background: Carbonic anhydrases (CAs) are a family of enzymes that regulate pH homeostasis in various tissues. CA IX 
is an exceptional member of this family because in addition to the basic CA function, it has been implicated in several 
other physiological and pathological processes. Functions suggested for CA IX include roles in cell adhesion and 
malignant cell invasion. In addition, CA IX likely regulates cell proliferation and differentiation, which was demonstrated 
in Car9-/- mice. These mice had gastric pit cell hyperplasia and depletion of chief cells; however, the specific molecular 
mechanisms behind the observed phenotypes remain unknown. Therefore, we wanted to study the effect of CA IX 
deficiency on whole-genome gene expression in gastric mucosa. This was done using Illumina Sentrix®Mouse-6 
Expression BeadChip arrays. The expression of several genes with notable fold change values was confirmed by QRT-
PCR.
Results: CA IX deficiency caused the induction of 86 genes and repression of 46 genes in the gastric mucosa. There 
was 92.9% concordance between the results obtained by microarray analysis and QRT-PCR. The differentially expressed 
genes included those involved in developmental processes and cell differentiation. In addition, CA IX deficiency altered 
the expression of genes responsible for immune responses and downregulated the expression of several digestive 
enzymes.
Conclusions: Microarray analysis identified several potential genes whose altered expression could explain the 
disturbed cell lineage phenotype in the Car9-/- gastric mucosa. The results also indicated a novel role for CA IX in the 
regulation of immunologic processes and digestion. These findings reinforce the concept that the main role of CA IX is 
not the regulation of pH in the stomach mucosa. Instead, it is needed for proper function of several physiological 
processes.
Background
The carbonic anhydrases (CAs) are a family of zinc-con-
taining metalloenzymes that catalyze the reversible
hydration of carbon dioxide in the reaction: CO2 + H2O ￿
H+ + HCO3
-. They participate in several physiological
processes, such as acid-base balance, CO2 and HCO3
-
transport, respiration, bone resorption, ureagenesis, glu-
coneogenesis, lipogenesis, production of body fluids, and
fertilization [1,2]. The CA family consists of 13 active
isozymes in mammals, 12 of which are expressed and
function in humans [3]. The CA isozymes have diverse
tissue expression patterns, characteristic subcellular
localizations, as well as unique kinetic and inhibitory
properties.
CA IX is a dimeric protein associated with the cell
membrane [4,5]. In its mature form, CA IX is composed
of an N-terminal proteoglycan (PG) domain, a CA cata-
lytic domain, a transmembrane region, and a short intra-
cytoplasmic tail at the C-terminus [6]. CA IX is the only
member of the CA family containing a PG domain in
addition to the CA domain. Consequently, CA IX has
been suggested to participate in cell adhesion processes.
In fact, using MDCK (Madin-Darby canine kidney) epi-
thelial cells, it was shown that CA IX reduces E-cadherin-
mediated cell-cell adhesion by interacting with β-catenin
[7].
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CA IX is expressed in only few normal tissues with the
expression being strongest in human, rat, and mouse gas-
tric mucosa, where it is present from the gastric pits to
the deep gastric glands [8,9]. CA IX is confined to the
basolateral surface of epithelial cells and is produced by
all major cell types of the gastric epithelium [8]. CA IX is
an exceptional member of the CA family because it is
expressed in several cancers that arise from CA IX nega-
tive tissues including renal, lung, cervical, ovarian, esoph-
ageal, and breast carcinomas [6]. However, gastric cancer
and premalignant lesions have shown decreased expres-
sion of CA IX [10]. In tumor tissues, CA IX is linked with
the hypoxic phenotype mediated by the hypoxia-induc-
ible transcription factor 1 (HIF-1), which binds to the
hypoxia responsive element, HRE, of the CA9 promoter
[11]. In hypoxic conditions, cancer cells are dependent
mainly on anaerobic metabolism in their energy produc-
tion. This anaerobic tumor metabolism generates
excesses of acidic products, such as lactic acid and H+
that have to be extruded from the cell interior. It has been
shown that CA IX can contribute to the acidification of
the hypoxic extracellular milieu, thus helping tumor cells
to neutralize the intracellular pH [12]. Accordingly, CA
IX overexpression often indicates poor prognosis and
resistance to classical radio- and chemotherapies [13].
However, CA IX is not only confined to the hypoxic
regions of the tumors, indicating that there might be
some other pathways that regulate its expression. In fact,
the expression of CA IX can be induced under normoxic
conditions by high cell density, and this regulation is
mediated by phosphatidylinositol 3-kinase (PI3K) signal-
ing [14]. Moreover, the mitogen-activated protein kinase
(MAPK) pathway is involved in the regulation of CA IX
expression via control of the CA9 promoter by both HIF-
1-dependent and -independent signals [15]. This pathway
is also interrelated with the PI3K pathway and the SP1
(specificity protein 1) transcription factor.
The generation of Car9-/- mice has revealed that in
addition to pH regulation and cell adhesion, CA IX pos-
sesses other functional roles [16]. These Car9 knockout
mice showed no abnormalities in growth, reproductive
p o t e n t i a l ,  a n d  l i f e  s p a n .  H o w e v e r ,  C A  I X  d e f i c i e n c y
resulted in hyperplasia of the gastric mucosa. The hyper-
plastic mucosa contained an increased number and pro-
portion of the mucus-producing pit cells whereas the
number and proportion of chief cells was reduced. The
total number of parietal cells remained unchanged, and
accordingly, CA IX-deficient mice had normal gastric pH,
acid secretion, and serum gastrin levels. Thus, these find-
ings demonstrate that CA IX contributes to the control of
differentiation and proliferation of epithelial cell lineages
in the gastric mucosa. A previous study examined
whether the effects of CA IX deficiency could be modi-
fied by a high-salt diet, a known co-factor of carcinogene-
sis [17]. These results showed that the high-salt diet
slightly increased the glandular atrophy in the body
mucosa in Car9-/- C57BL/6 mice, whereas this effect was
not observed in BALB/c mice. However, no metaplastic
or dysplastic abnormalities were seen in the gastrointesti-
nal epithelium of CA IX-deficient C57BL/6 mice. Thus,
these observations suggest that CA IX deficiency alone
may not be a significant carcinogenic factor but could ini-
tiate a carcinogenic process by affecting cell proliferation
and/or differentiation in the gastric mucosa.
T h i s  s t u d y  w a s  d e s i g n e d  t o  b e t t e r  u n d e r s t a n d  t h e
hyperplastic phenotype of the stomach mucosa of Car9-/-
mice because the molecular mechanisms behind it are
currently unknown. In addition, we wanted to more spe-
cifically elucidate the functional roles of CA IX, as there is
a growing body of evidence showing that they extend far
beyond pH regulation. For this purpose, a genome-wide
expression analysis was performed. Microarray data anal-
ysis revealed several genes whose expression was changed
due to Car9 gene disruption in the gastric mucosa.
Results
Transcriptional response to Car9 deficiency in the stomach 
wall
Stomach RNA from 6 Car9-/- mice and 6 wild-type mice
was analyzed by microarray. The analysis revealed 86
upregulated genes and 46 downregulated genes, using a
fold change cut-off of ± 1.4 for up- and downregulated
e x p r e s s i o n ,  r e s p e c t i v e l y  ( S e e  a d d i t i o n a l  f i l e  1 :  L i s t  o f
genes differentially expressed in the stomach of Car9-/-
mice). This cut-off value has been proposed as an ade-
quate level above which there is a high correlation
between microarray and QRT-PCR data, regardless of
other factors such as spot intensity and cycle threshold
[18]. The fold changes ranged from 10.46 to -12.14.
Herein, a list of genes using a cut-off value of ± 2.5-fold is
shown (Tables 1 and 2). When using these criteria, all the
genes with significantly (p < 0.05) altered expression are
displayed, that is, 14 genes with induced expression and
21 genes with repressed expression. The list of all the reg-
ulated genes was functionally annotated (see additional
file 2: Functional annotation of genes regulated in the
stomach of Car9 knockout mice), showing enrichment of
hydrolase activity, developmental processes, cell differen-
tiation, proteolysis, peptidase activity, structural mole-
cule activity, and immune system process, among others.
The functional annotation categories and gene numbers
in each category are shown in Table 3.
Confirmation of microarray results by QRT-PCR
Changes in the expression levels of selected genes were
confirmed, and microarray results were validated by
QRT-PCR using the same RNA samples as those used for
the microarray. Fourteen genes with notable fold changeKallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
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Table 1: Genes with upregulated expression using a cut-off value of 2.5-fold.
Gene symbol Description GenBank number FC QRT-PCR
Cym chymosin NM_001111143 10.46 19.66
Slc9a3 solute carrier family 9 (sodium/hydrogen exchanger), member 3 NM_001081060 8.07 10.72
U46068 cDNA sequence U46068, transcript variant 2 NM_153418 5.95
Dmbt1 deleted in malignant brain tumors 1 NM_007769 5.68 5.29
Il1rl1 interleukin 1 receptor-like 1, transcript variant 2 NM_010743 5.38 8.95
Tm4sf5 transmembrane 4 superfamily member 5 NM_029360 4.26
9130204L05Rik RIKEN cDNA 9130204L05 gene NM_001101461 4.19
Sftpd surfactant associated protein D NM_009160 4.11 3.69
Nccrp1 non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) NM_001081115 3.81
Pkp4 plakophilin 4, transcript variant 1 NM_026361 3.54 1.09
Sprr2d small proline-rich protein 2D NM_011470 3.46
Gm14446 predicted gene 14446, transcript variant 2 NM_001101605 3.45
Sprr3 small proline-rich protein 3 NM_011478 3.39
Sprr2i small proline-rich protein 2I NM_011475 3.31
Sprr1a small proline-rich protein 1A NM_009264 3.30
Ivl involucrin NM_008412 3.08
Serpinb12 serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 12 NM_027971 3.02
Krt10 keratin 10 NM_010660 3.01
Gm94 predicted gene 94 NM_001033280 2.94
Krt13 keratin 13 NM_010662 2.94
Gsdmc2 gasdermin C2, transcript variant 2 NM_177912 2.88
Lor loricrin NM_008508 2.84
Dmkn dermokine, transcript variant 2 NM_172899 2.78
Ly6d lymphocyte antigen 6 complex, locus D NM_010742 2.69
Krt1 keratin 1 NM_008473 2.52Kallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
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Table 2: Genes with downregulated expression using a cut-off value of -2.5-fold.
Gene symbol Description GenBank number FC QRT-PCR
Try4 trypsin 4 NM_011646 -12.14
Prss1 protease, serine, 1 (trypsin 1) NM_053243 -10.57
Amy2a5 amylase 2a5, pancreatic NM_001042711 -9.85
Cela2a chymotrypsin-like elastase family, member 2A NM_007919 -7.59 -16.23
Gm12888 predicted gene 12888 NM_001033791 -7.12
Gdf9 growth differentiation factor 9 NM_008110 -7.04
Blm bloom syndrome homolog (human), transcript variant 1 NM_007550 -6.27
Pnlip pancreatic lipase NM_026925 -6.23 -23.88
Cfd complement factor D (adipsin) NM_013459 -5.35 -27.45
Ctrb1 chymotrypsinogen B1 NM_025583 -5.00
Mug1 murinoglobulin 1 NM_008645 -4.30
Sostdc1 sclerostin domain containing 1 NM_025312 -4.17
Tmed6 transmembrane emp24 protein transport domain 
containing 6
NM_025458 -4.07
Cpa1 carboxypeptidase A1 NM_025350 -3.95
Slc27a2 solute carrier family 27 (fatty acid transporter), member 2 NM_011978 -3.80
Adipoq adiponectin, C1Q and collagen domain containing NM_009605 -3.74 -20.51
Car3 carbonic anhydrase 3 NM_007606 -3.72 -15.39
Egf epidermal growth factor NM_010113 -3.68 -3.71
Abpg androgen binding protein gamma NM_178308 -3.67
Slc38a5 solute carrier family 38, member 5 NM_172479 -3.64
Chia chitinase, acidic NM_023186 -3.52
LOC638418 PREDICTED: similar to Ela3 protein XM_914439 -3.48Kallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
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values were selected for validation based on the results of
functional annotation. The selected genes involved repre-
sentatives from different functional categories. Thirteen
(92.9%) out of 14 genes showed concordant results
between microarray analysis and QRT-PCR (Tables 1 and
2, Figure 1). The sole discrepant result was Pkp4, which
was upregulated according to the microarray and did not
change according to the QRT-PCR (1.09-fold).
Discussion
A previous study showed a hyperplastic phenotype of
gastric body mucosa in Car9-/- mice [16]. CA IX defi-
ciency led to overproduction of gastric pit cells and
reduction of chief cells. Quite surprisingly, the gastric pH
of CA IX-deficient mice remained unaltered. Based on
these observations, it can be concluded that the main role
of CA IX in the stomach mucosa is not related to pH reg-
ulation but it is required for normal gastric morphogene-
sis and homeostasis within the gastric mucosa. In this
paper, we report alterations in mRNA expression that
might contribute to the phenotypic changes reported in
the stomach of Car9-deficient mice. However, one must
take into consideration that some of these changes can
merely reflect differences in the relative proportions of
various cell types within the gastric mucosa.
As expected, the Car9-/- phenotype changed the expres-
sion of genes involved in developmental processes and
cell differentiation. The depletion of chief cells in Car9-/-
gastric mucosa may be explained by the significant down-
regulation of the basic helix-loop-helix family, member
a15/Mist1 (Bhlha15) gene, which is a class B basic helix-
loop-helix (bHLH) transcription factor that exhibits aci-
nar cell-specific expression [19]. Mist1 gene expression is
observed in a wide array of tissues with serous type secre-
tion including the pancreas, salivary glands, chief cells of
the stomach, Paneth cells of the small intestine, seminal
vesicles, and lacrimal glands [20]. The deletion of Mist1
blocks normal mucous neck cell redifferentiation into
zymogenic chief cells as all basal zymogen-secreting cells
in Mist1-/- mice show multiple structural defects [21].
Another interesting candidate with regard to cell lin-
eage disturbance in the gastric epithelium of CA IX-defi-
LOC100043836 PREDICTED: similar to lacrimal androgen-binding 
protein delta, transcript variant 1
XM_001481113 -3.41
EG640530 PREDICTED: predicted gene, EG640530 XM_917532 -3.37
Nrn1 neuritin 1 NM_153529 -3.36
Cela3b chymotrypsin-like elastase family, member 3B NM_026419 -3.32 -75.74
Spink3 serine peptidase inhibitor, Kazal type 3 NM_009258 -3.32
Scd1 stearoyl-Coenzyme A desaturase 1 NM_009127 -3.27
Ctrl chymotrypsin-like NM_023182 -3.19
Gper G protein-coupled estrogen receptor 1 NM_029771 -2.96
Sycn syncollin NM_026716 -2.91
Bhlha15 basic helix-loop-helix family, member a15 NM_010800 -2.77
Cpb1 carboxypeptidase B1 (tissue) NM_029706 -2.73 -18.22
Slc5a8 solute carrier family 5 (iodide transporter), member 8 NM_145423 -2.68
Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 NM_021282 -2.65
Zg16 zymogen granule protein 16 NM_026918 -2.57
Table 2: Genes with downregulated expression using a cut-off value of -2.5-fold. (Continued)Kallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
Page 6 of 14
Table 3: The functional annotation categories for the genes regulated by CA IX deficiency.
Functional category Total regulated genes Upregulated genes Downregulated genes
Developmental processes* 20 13 7
Keratinization and keratinocyte differentiation 8 8 0
Structural molecule activity 13 13 0
Embryo implantation, female pregnancy, and 
menstrual cycle
33 0
Rhythmic process 4 3 1
Multi-organism process 5 5 0
Cell differentiation 16 12 4
Serine-type endopeptidase activity, serine hydrolase 
activity, and serine-type peptidase activity
93 6
Proteolysis 15 6 9
Peptidase activity 14 5 9
Endopeptidase activity 10 4 6
Trypsin and chymotrypsin activity 4 1 3
Hydrolase activity 22 8 14
Structural constituent of cytoskeleton 5 5 0
Cell communication 4 4 0
Metallocarboxypeptidase activity, carboxypeptidase 
activity, and metalloexopeptidase activity
30 3
Serine-type endopeptidase inhibitor activity, 
endopeptidase inhibitor activity, and protease 
inhibitor activity
42 2
Taxis and chemotaxis 4 3 1
Response to external stimulus 7 4 3
Immune system process 10 5 5
Defense response 7 5 2Kallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
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cient mice is epidermal growth factor (Egf), which has an
expression that was significantly decreased when com-
pared to wild-type mice. Among growth factors, the EGF
family includes important agents for gastric mucosa. EGF
is a single-chain polypeptide of 53 amino acid residues,
which is found mainly in the submandibular glands and
Brunner's glands of the gastrointestinal tract [22]. EGF
binds and activates the epidermal growth factor receptor
resulting in cellular proliferation, differentiation, and sur-
vival [23]. Interestingly, several investigators have
reported that EGF receptors are enriched in rodent chief
cells [24,25], suggesting the importance of EGF function
in these cells. Therefore alterations in the expression of
EGF receptor ligands or, in this case, EGF could contrib-
ute to the differentiation and function of chief cells.
One of the most strongly upregulated genes of this
study was deleted in malignant brain tumors 1 (Dmbt1),
which belongs to the scavenger receptor cysteine-rich
(SRCR) superfamily of proteins. This is a superfamily of
secreted and membrane-bound proteins with SRCR
domains that are highly conserved down to sponges
[26,27]. The expression of DMBT1 is the highest in epi-
thelia and is usually observed on the apical cell surface or
in luminal exocrine secretions. In mice, DMBT1 is most
strongly expressed in the gastrointestinal system [28].
DMBT1 is proposed to be a tumor suppressor [26,29,30]
and/or a regulator of epithelial differentiation [31], as well
as having roles in innate immune defense and inflamma-
tion [32,33]. DMBT1 is located in the crypt cells of the
human, mouse, and rabbit small intestine [31,34,35] and
the neck region of normal human gastric mucosa [36],
which are predominantly composed of stem/progenitor
cells. Thus, this gene is potentially involved in the physio-
logical renewing process of gastrointestinal epithelia. A
role for DMBT1 in innate immune defense has been dem-
onstrated in various studies. The human DMBT1 glyco-
protein, expressed in salivary glands, airways, and genital
tract, binds various bacterial pathogens and viruses [37-
40]. Additionally, expression of mouse DMBT1 in the
gastrointestinal tract is regulated by bacteria [41,42], and
its expression is increased during infection [43]. It has
also been shown that there is an association of a Dmbt1
variant allele with Crohn's disease and there is a correla-
tion of expression levels of Dmbt1  with inflammatory
bowel disease severity [44].
Furthermore, DMBT1 binds surfactant proteins SP-D
and SP-A. These are collagen- containing, (C-type) cal-
cium-dependent lectins called collectins which interact
with glycoconjugates and lipids on the surface of micro-
organisms mostly through their carbohydrate recognition
domains (CRDs) [45]. SP-D and SP-A are involved in a
range of immune functions, including viral neutraliza-
tion, aggregation and killing of bacteria and fungi, and
clearance of apoptotic and necrotic cells. In immunologi-
cally naïve lungs, they downregulate inflammatory reac-
tions, but when challenged with LPS or apoptotic cells
they induce phagocytosis by macrophages, pro-inflam-
matory cytokine production, and enhancement of adap-
tive immune responses [46]. It is interesting that in the
present study, in addition to Dmbt1, the expression of
surfactant associated protein D (Sftpd or SP-D) was
highly induced in Car9-/- mice. Thus, the upregulation of
both  Dmbt1  and  Sftpd  suggest that CA IX deficiency
induced an immune process in the gastric mucosa. It
should also be noted that CA IX has been suggested to
bind to dendritic cells in a receptor-mediated manner
and scavenger receptors appear to play an important role
in this process [47]. In addition, CA IX seems to activate
an immune response by a mechanism characteristic to
heat shock proteins. Thus, CA IX could directly interact
with DMBT1 via a scavenger receptor.
In fact, the disruption of Car9 gene caused disregula-
tion of several genes that are involved in immune pro-
cesses. This corroborates the results from a previous
study where gastric submucosal inflammation was
d e t ec t e d  i n  t h e  bod y  r e g i o n  i n  a  m a j o r i t y  o f  C 5 7 B L / 6
Car9-/- mice [17]. In the present study, Il1rl1/ST2 tran-
script variant 2 mRNA was highly induced due to CA IX
deficiency. The Il1rl1/ST2 gene is a member of the inter-
leukin-1 (IL-1) receptor family and produces a soluble
secreted form (sST2) and a transmembrane form (ST2L),
coded by transcript variants 2 and 1, respectively. The
membrane-bound form is expressed primarily by
hematopoietic cells and the soluble form is predomi-
nantly expressed by fibroblasts [48]. In particular, ST2L is
preferentially expressed in murine and human Th2 cells
Positive regulation of cell differentiation 3 2 1
PPAR signaling pathway 3 0 3
Leukocyte migration 3 2 1
*A representative category for the following overlapping categories: epidermis morphogenesis, tissue morphogenesis, epidermis 
development, ectoderm development, tissue development, organ development, anatomical structure development, anatomical structure 
morphogenesis, cellular developmental process, multicellular organismal development, and epidermal cell differentiation.
Table 3: The functional annotation categories for the genes regulated by CA IX deficiency. (Continued)Kallio et al. BMC Genomics 2010, 11:397
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Figure 1 Verification of microarray data from Car9-/- mice by QRT-PCR. The expression of various transcripts in 6 Car9-/- mice was compared to 
that in 6 wild-type controls. The normalized values of triplicate experiments are shown. A, QRT-PCR analysis of 6 genes with induced expression. B, 
QRT-PCR evaluation of 8 genes with repressed expression. Statistically significant differences relative to wild-type mice were determined. *p < 0.05; 
**p < 0.01.Kallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
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and can be used as a specific marker of Th2 cells in in
vitro  experiments [49-52]. Therefore, the function of
ST2L has been suggested to correlate with Th2 cell-medi-
ated immunological responses and IL-33, a newly discov-
ered member of the IL-1 cytokine family, has been
reported as a specific ligand for ST2L [53]. Interestingly,
several studies have shown that the level of soluble ST2 in
sera is elevated in asthmatic disease [54,55]. Therefore, it
has been suggested that soluble ST2 may also play a criti-
cal role in Th2 cell-mediated diseases. In fact, it has been
demonstrated that soluble ST2 acts as an antagonistic
decoy receptor for IL-33 using a murine thymoma cell
line, EL-4, which stably expresses ST2L, and a murine
model of asthma [56]. This suggests that soluble ST2 neg-
atively modulates the production of Th2 cytokines
through IL-33 signaling in allergic airway inflammation.
It is interesting to note that in the present study, the
mRNA level of IL-33 was also elevated ~ 2-fold, although
this change was not statistically significant. Thus, it
seems plausible that CA IX is somehow involved in regu-
lation of the Th2 response.
CA IX could also contribute to the development of the
immune system as CA IX deficiency significantly down-
regulated the bloom syndrome homolog (human) gene
(Blm), which encodes an ATP-dependent DNA helicase
that belongs to an evolutionarily conserved family of
RecQ helicases [57]. Mutation of Blm  causes a rare
human autosomal recessive disorder called Bloom's syn-
drome (BS), which is characterized by marked genomic
instability. BS is associated with growth retardation, pro-
found susceptibility to most cancer types, and immuno-
deficiency [58], with the latter two features accounting
for early death [59]. The functions of BLM have been only
partially characterized. However, it has been shown that
BLM has a role in the proliferation and survival of both
developing and mature T lymphocytes, and its deletion
leads to defective T-cell immunity [60]. Additionally, the
conditional knockout of Blm  contributed to compro-
mised B cell development and maintenance, strongly
impaired T cell-dependent and -independent antibody
responses after immunization, and a propensity for devel-
oping B cell lymphomas [61]. Therefore, it is conceivable
that Car9-/- mice have compromised acquired immunity
responses.
An unexpected finding was that several small proline-
rich proteins (Sprr) were notably upregulated including
Sprr1a, Sprr2d, Sprr2e, Sprr2i, and Sprr3. However, only
the induction of Sprr1a was statistically significant. SPRR
proteins were originally identified as markers for terminal
squamous cell differentiation where they are precursors
of the cornified envelope [62]. Additionally, SPRR pro-
teins are expressed in various nonsquamous tissues, and
their biological function is not restricted to structural
proteins of the cornified envelope [63]. It has been shown
that SPRR proteins participate in the response to various
stresses in many tissues without a stratified epithelium. In
the biliary tract, SPRR2 members appear to contribute to
modification of the biliary barrier under conditions of
stress [64]. Likewise, SPRR1A has been identified as a
novel stress-inducible downstream mediator of gp130
cytokines in cardiomyocytes with a cardioprotective
effect against ischemic stress [65]. Furthermore, in mice,
SPRR2A protein was reported to be highly induced in
gastric mucosa infected by Helicobacter heilmannii [66].
In addition, it has been suggested that SPRR1A is a regen-
eration-associated protein because its induction in neu-
ronal injury correlates with regenerative capacity, with
virtually all injured dorsal root ganglion neurons express-
ing SPRR1A one week after sciatic nerve injury [67].
Therefore, SPRR genes are presumably induced in
response to different stress conditions and contribute to
cell protection, tissue remodeling, and/or tissue regenera-
tion. In the light of these findings it seems plausible that
CA IX deficiency creates a stress condition in the gastric
mucosa, which leads to upregulation of some protective
factors.
Our analysis identified mRNAs from four members of
solute carrier family proteins to be misregulated in the
Car9-/- mice stomach mucosa. These solute carrier pro-
teins are involved in membrane transport of various mol-
ecules. The expression of Slc9a3 was strongly induced,
whereas the expression of Slc27a2, Slc38a5, and Slc5a8
was repressed. The basic function of SLC9A3 or NHE3 is
the exchange of extracellular Na+ for intracellular H+,
thus causing either a rise in intracellular pH or, if coupled
to the action of other transporters, an increase in cell vol-
ume [68]. In the gastrointestinal tract, SLC9A3 is
expressed in the apical membrane and recycling endo-
somes of the ileum, jejunum, colon, and stomach [69].
Further studies are needed to elucidate the possible inter-
play between CA IX and SLC9A3 in the gastric mucosa.
Surprisingly, among the most downregulated genes we
found several genes involved in digestion. These included
trypsin 1, amylase 2a5, chymotrypsin-like elastase family
member 2A, and pancreatic lipase with statistically signif-
icant p-values and others, such as chymotrypsinogen B1,
carboxypeptidase A1, and carboxypeptidase B1 with non-
significant p-values. The implication of this finding
remains unclear. A possible explanation for this might be
that downregulation of these enzymes is a secondary
event. If it is assumed that these enzymes are produced
by chief cells, the reduced number of chief cells in the
Car9-/- mice gastric mucosa can also cause a decrease in
the amount of the enzymes they produce. However, the
exact mechanism behind this phenomenon remains to be
elucidated.Kallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
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Conclusions
In conclusion, CA IX deficiency was shown to alter the
expression of various genes in the gastric mucosa. The
number of affected genes and the magnitude of changes
were relatively high, indicating that CA IX has a remark-
able role in gastric functions. Microarray analysis
revealed several genes involved in developmental pro-
cesses and cell differentiation, which could explain the
cell lineage disturbance in the gastric epithelium of Car9-
/- mice. Interestingly, some of the regulated genes identi-
fied in this study are involved in digestion as well as func-
tions of the immune and defense responses. This finding
suggests that CA IX deficiency compromises the immune
system in the gastric epithelium implying yet another role
for this multifunctional enzyme.
Methods
Animal model and tissue preparation
Generation of the targeted disruption of the Car9 gene
has been previously described by Ortova Gut et al. [16].
These Car9-deficient C57BL/6 mice were produced and
maintained in the animal facility of the University of Oulu
and then delivered to the animal facility of the University
of Tampere. Permissions for use of the experimental mice
were obtained from the Animal Care Committees of the
Universities of Oulu and Tampere. Six Car9-/- mice (3
males and 3 females) and six wild-type control mice (3
males and 3 females) were kept under tightly controlled
specific pathogen-free conditions and fed identical diets.
The mice were sacrificed at approximately 11 (SD = ±
1.35) months of age. Tissue specimens from the body of
the stomach were immediately collected, immersed in
RNAlater solution (Ambion, Austin, TX, USA), and fro-
zen at -80°C.
RNA isolation
Total RNA was obtained using the RNeasy RNA isolation
kit (Qiagen, Valencia, USA) following the manufacturer's
instructions. Residual DNA was removed from the sam-
ples using RNase-free DNase (Qiagen). The RNA concen-
tration and purity were determined by measurement of
the optical density (OD) at 260 and 280 nm. All samples
had an OD260/OD280 ratio of 1.95 or higher.
Microarray analysis
All microarray data reported in the present article are
described in accordance with MIAME guidelines, have
b e e n  d e p o s i t e d  i n  N C B I ' s  G e n e  E x p r e s s i o n  O m n i b u s
public repository [70], and are accessible through GEO
Series accession number GSE20981 [71]. Microarray
experiments were performed in the Finnish DNA
Microarray Centre at the Turku Centre for Biotechnol-
ogy. Stomach RNA samples from 6 Car9-/- mice were
used. As controls, RNA samples from the stomach of 6
wild-type mice were used. All 12 samples were analyzed
individually. 400 ng of total RNA from each sample was
amplified using the Illumina® TotalPrep RNA Amplifica-
tion kit (Ambion) as recommended by the manufacturer.
The in vitro transcription reaction, which was conducted
for 14.5 h, included labeling of the cRNA by biotinylation.
Hybridization and scanning
Labeled and amplified cRNAs (1.5 μg/array) were hybrid-
ized to Illumina's Sentrix®  Mouse-6 Expression Bead
Chips (Illumina, Inc., San Diego, CA) at 58°C for 18 h
according to Illumina® Whole-Genome Gene Expression
with IntelliHyb Seal System Manual. The arrays were
washed and then stained with 1 μg/ml cyanine3-strepta-
vidin (Amersham Biosciences, Buckinghamshire, UK).
The Illumina BeadArray™ Reader was used to scan the
arrays according the manufacturer's instructions. The
numerical results were extracted with the Illumina's
BeadStudio software without any normalization or back-
ground subtraction.
Data analysis
Array data were normalized with Chipster (v1.3.0) using
the quantile normalization method. The data were fil-
tered according to the SD of the probes. The percentage
of data that did not pass through the filter was adjusted to
99.4%, implicating a SD value of almost 3. Statistical anal-
ysis was next performed using the empirical Bayes t-test
for the comparison of two groups. Finally, the probes
were further filtered according to fold change with ± 1.4
as the cut-off for up- and downregulated expression,
respectively. The functional annotation tool DAVID
(Database for Annotation, Visualization and Integrated
Discovery) [72,73] was used to identify enriched biologi-
cal categories among the regulated genes when compared
to all the genes present on Illumina's Sentrix Mouse-6
Expression Bead Chip. The annotation groupings ana-
lyzed were Gene Ontology biological process and molec-
ular functions, SwissProt comments, SwissProt Protein
Information Resources Keywords, Kyoto Encyclopedia of
Genes and Genomes pathway, and Biocarta pathway.
R e s u l t s  w e r e  f i l t e r e d  t o  r e m o v e  c a t e g o r i e s  w i t h  E A S E
(Expression Analysis Systematic Explorer) scores greater
than 0.05. Overlapping categories with the same gene
members were removed to yield a single representative
category.
Quantitative real-time PCR
For quantitative real-time PCR (QRT-PCR), the same
samples were used as for the microarray analysis. 5 μg of
each RNA sample was converted into first strand cDNA
using a First Strand cDNA Synthesis Kit (Fermentas, Bur-
lington, Canada) using random hexamer primers follow-
ing the manufacturer's instructions. The relativeK
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Table 4: Sequences of the QRT-PCR primers used in this study.
Gene symbol Description GenBank number Forward primer (5'-3') Reverse primer (5'-3')
Adipoq adiponectin, C1Q and collagen domain containing NM_009605 TCCTGCTTTGGTCCCTCCAC TCCTTTCTCTCCCTTCTCTCC
Car3 carbonic anhydrase 3 NM_007606 GCTCTGCTAAGACCATCC ATTGGCGAAGTCGGTAGG
Cela2a chymotrypsin-like elastase family, member 2A NM_007919 TGATGTGAGCAGGGTAGTTGG CACTCGGTAGGTCTGATAGTTG
Cela3b chymotrypsin-like elastase family, member 3B NM_026419 TGCCTGTGGTGGACTATGAA CAGCCCAAGGAGGACACAA
Cfd complement factor D (adipsin) NM_013459 AACCGGACAACCTGCAATC CCCACGTAACCACACCTTC
Cpb1 carboxypeptidase B1 (tissue) NM_029706 GGTTTCCACGCAAGAGAG GTTGACCACAGGCAGAACA
Cym chymosin NM_001111143 ATGAGCAGGAATGAGCAG TGACAAGCCACCACTTCACC
Dmbt1 deleted in malignant brain tumors 1 NM_007769 GCACAAGTCCTCCATCATTC AGACAGAGCAGAGCCACAAC
Egf epidermal growth factor NM_010113 GCTCGGTGTTTGTGTCGTG CTGTCCCATCATCGTCTGG
Il1rl1 interleukin 1 receptor-like 1, transcript variant 2 NM_010743 ATTCTCTCCAGCCCTTCATC AAGCCCAAAGTCCCATTCTC
Pkp4 plakophilin 4, transcript variant 1 NM_026361 GAACATAACCAAAGGCAGAGG GGTGGACAGAGAAGGGTGTG
Pnlip pancreatic lipase NM_026925 CCCGCTTTCTCCTCTACACC TCACACTCTCCACTCGGAAC
Sftpd surfactant associated protein D NM_009160 CCAACAAGGAAGCAATCTGAC TCTCCCATCCCGTCCATCAC
Slc9a3 solute carrier family 9 (sodium/hydrogen exchanger), member 3 NM_001081060 TGACTGGCGTGGATTGTGTG ACCAAGGACAGCAGGAAGG
Actb actin, beta NM_007393 AGAGGGAAATCGTGCGTGAC CAATAGTGATGACCTGGCCGT
Hprt hypoxanthine guanine phosphoribosyl transferase NM_013556 AGCTACTGTAATGATCAGTCAACG AGAGGTCCTTTTCACCAGCA
Sdha succinate dehydrogenase complex, subunit A NM_023281 GCTTGCGAGCTGCATTTGG CATCTCCAGTTGTCCTCTTCCAKallio et al. BMC Genomics 2010, 11:397
http://www.biomedcentral.com/1471-2164/11/397
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expression levels of the target genes in the stomach wall
were assessed by QRT-PCR using the LightCycler detec-
tion system (Roche, Rotkreuz, Switzerland). The primer
sets for the target genes (Table 4) were designed using
Primer3 [74], based on the complete cDNA sequences
deposited in GenBank. The specificity of the primers was
verified using NCBI Basic Local Alignment Search Tool
(BLAST) [20]. The house-keeping genes β-actin (Actb),
hypoxanthine guanine phosphoribosyl transferase (Hprt),
and succinate dehydrogenase complex, subunit A (Sdha)
were used as internal controls to normalize the cDNA
samples for possible differences in quality and quantity
(Table 4). The Actb and Hprt primers are available in the
public Quantitative PCR Primer Database [75] under the
identification numbers 634 and 10050, respectively. The
Sdha primers were obtained from the public PrimerBank
database [76] with the identification number 15030102a2.
To avoid amplification of genomic DNA, the primers
from each primer pair were located in different exons,
when possible.
Each PCR reaction was performed in a total volume of
20 μl containing 0.5 μl of first strand cDNA, 1x of Quanti-
Tect SYBR Green PCR Master Mix (Qiagen, Hilden, Ger-
many), and 0.5 μM of each primer. Amplification and
detection were carried out as follows: after an initial 15
min activation step at 95°C, amplification was performed
in a three-step cycling procedure for 45 cycles: denatur-
ation at 95°C for 15 s, annealing at a temperature deter-
mined according to the Tm for each primer pair for 20 s,
and elongation at 72°C for 15 s (the ramp rate was 20°C/s
for all the steps), followed by a final cooling step. Melting
curve analysis was always performed after the amplifica-
tion to examine the specificity of the PCR. To quantify
the levels of the target transcripts, a standard curve was
established for each gene using five-fold serial dilutions of
known concentrations of purified PCR products gener-
ated with the same primer pairs. Every cDNA sample was
tested in triplicate. The mean and SD of the 3 crossing
point (Cp) values were calculated for each sample and a
SD cut-off of 0.2 was set. Accordingly, when the SD of the
triplicates of a sample was greater than 0.2, the most out-
lying replicate was excluded and the analysis was contin-
ued with the two remaining replicates. Using a specific
standard curve, the Cp values were then transformed by
the LightCycler software into copy numbers. The expres-
sion value for each sample was the mean of the copy
numbers for the sample's replicates. The geometric mean
of the three internal control genes was used as an accu-
rate normalization factor for gene expression levels [77].
The final relative mRNA expression was given as the
expression value of the sample divided by the corre-
sponding normalization factor and multiplied by 103.
Statistical analyses
Statistical analyses of the microarray were performed
using the empirical Bayes t-test for comparison of the two
groups, and the p-values are shown in Additional file 1.
For the QRT-PCR results, the Mann-Whitney test was
used to evaluate differences in group values for Car9-/-
mice vs. wild-type mice.
List of abbreviations used
CA IX: carbonic anhydrase IX; HIF-1: hypoxia-inducible
transcription factor 1; HRE: hypoxia responsive element;
MAPK: mitogen-activated protein kinase; PI3K: phos-
phatidylinositol 3-kinase; QRT-PCR: quantitative real-
time PCR.
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